CRYOPORT, INC. Increase (Decrease) in Accrued Liabilities
CRYOPORT, INC. (CYRX) reported Increase (Decrease) in Accrued Liabilities of $174.01 thousand for the 9-month period ending 2013-12-31, per its 10-Q filed 2014-02-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2014-02-13
- 2013-12-31: Increase (Decrease) in Accrued Liabilities 9 month $174.01K.
- 2012-12-31: Increase (Decrease) in Accrued Liabilities 9 month -$67.53K.
| Period end | Increase (Decrease) in Accrued Liabilities 9 month |
|---|---|
| 2013-12-31 | $174.01K 10-Q · filed 2014-02-13 |
| 2012-12-31 | -$67.53K 10-Q · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |